EUVIMEDEUVIMED entdecken
Crossref

Early initiation or ongoing treatment? Interpreting sodium–glucose cotransporter 2 inhibitor use after acute coronary syndrome

Jian Tian iD

Diabetic Medicine · 16.11.2026

DOI: 10.1111/dme.70533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetic Medicine, online erschienen am 16.11.2026. Verfasst von Jian Tian. Beteiligte Einrichtung: Outpatient Department, Suizhou Hospital of Traditional Chinese Medicine, Suizhou, Hubei, China. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Outpatient Department, Suizhou Hospital of Traditional Chinese Medicine, Suizhou, Hubei, China.

ORCID-Profile: Jian Tian

Zitieren

APA

Tian, J. (2026). Early initiation or ongoing treatment? Interpreting sodium–glucose cotransporter 2 inhibitor use after acute coronary syndrome. Diabetic Medicine. https://doi.org/10.1111/dme.70533

Vancouver

Tian J. Early initiation or ongoing treatment? Interpreting sodium–glucose cotransporter 2 inhibitor use after acute coronary syndrome. Diabetic Medicine. 2026. doi:10.1111/dme.70533

BibTeX
@article{Tian2026,
  author = {Tian, Jian},
  title = {Early initiation or ongoing treatment? Interpreting sodium–glucose cotransporter 2 inhibitor use after acute coronary syndrome},
  journal = {Diabetic Medicine},
  year = {2026},
  doi = {10.1111/dme.70533}
}
Kostenlos starten →